FINWIRES · TerminalLIVE
FINWIRES

VPower Group's Offshore Debt Restructuring Agreement Lapses; Shares Plunge 29%

By

VPower Group's (HKG:1608) proposed offshore debt restructuring lapsed after failing to become effective by the longstop date, according to a Thursday Hong Kong bourse filing.

Shares of the distributed power provider were down over 29% in late morning trade on Friday.

The restructuring agreement, signed in November 2025, covered about HK$2.08 billion in offshore debt and included plans to extend remaining maturities by 5.5 years from Sept. 2, reduce interest rates and waive certain existing breaches.

Upon completion, the offshore debt would have been reduced to a restated principal of about HK$1.38 billion.

VPower said no agreement had been reached with lenders to further extend the longstop date under the restructuring master agreement.

The company said it is continuing to work with professional advisers on a holistic restructuring solution for its offshore debts and other outstanding obligations.

Related Articles

Asia

Alibaba Health Seeks 10 Billion Yuan Share Premium Cut to Support Dividends; Shares Fall 7%

Alibaba Health Information Technology (HKG:0241) proposed a 10 billion yuan reduction in its share premium account to facilitate dividend distributions, according to a Thursday Hong Kong bourse filing.Shares of the digital health service provider fell 7% in late morning trade on Friday.The company said the proposed reduction would transfer the amount from its share premium account to contributed surplus, enabling payment of a final dividend and a special dividend for the year ended March 31.Alibaba Health proposed a final dividend of 0.0595 yuan per share and a special dividend of 0.1352 yuan per share.The company said the proposal was necessary because it had insufficient contributed surplus available for distribution.Alibaba Health's share premium account stood at about 51.7 billion yuan as of March 31, the filing showed.

$HKG:0241
Asia

Prestige Biologics Secures KRW2.4 Billion Contract Manufacturing Agreement for APIs

Prestige Biologics (KOSDAQ:334970) secured a contract manufacturing agreement for active pharmaceutical ingredients (APIs) following a technology transfer from an undisclosed client, according to a Friday filing with the Korea Exchange.The deal, valued at 2.40 billion won, is valid till March 31, 2027.Shares of Prestige Biologics fell nearly 2% in recent trade.

$KOSDAQ:334970
Asia

Thai Beverage's Attributable Profit Up 9% in Fiscal Q2

Thai Beverage's (SGX:Y92) attributable profit to owners rose 9% during the fiscal second quarter ended March 31 to 7.37 billion baht from 6.74 billion baht a year earlier, according to a Thursday filing with the Singapore Exchange.Shares of the beverage producer were up over 1% in Friday trading.Earnings per share came in at 0.29 baht compared with 0.27 baht in the year-ago period.Revenue from sale of goods inched up 1% year over year to 86.5 billion baht from 85.4 billion baht.The board approved an interim dividend of 0.15 baht per share for the period, unchanged from a year earlier. The dividend will be paid on June 12.

$SGX:Y92